A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro

European Journal of Immunology
D ChristiansenB E Loveland

Abstract

The human cell surface complement regulatory proteins CD46 (MCP), CD55 (DAF) and CD35 (CR1) protect autologous cells from complement-mediated damage by inhibiting C3 and C5 convertases. This regulatory potential has previously been exploited in the treatment of some models of inflammatory injury by the generation of recombinant soluble (rs) proteins, such as rsCD55 and rsCD35 . More recently, we have shown that rsCD46 inhibits complement activation in the fluid phase. In this report, the ability of rsCD46, rsD55 and rsCD35 to regulate human complement activation mediated by the classical pathway in vitro was clearly demonstrated by all three soluble proteins; however, rsCD35 was a more effective inhibitor than either rsCD46 or rsCD55. A combination of rsCD46+ rsCD55 was more potent than either of these proteins alone. Cell lysis via alternative pathway activation in vitro was efficiently regulated by rsCD46 and rsCD35 to a similar extent, whereas rsCD55 was not effective. Assays of rsCD46 in vivo have previously not been possible due to difficulties in expressing sufficient quantities of protein. This limitation has been overcome and now we report the ability of rsCD46 to inhibit immune complex-mediated inflammation in a rat us...Continue Reading

References

Apr 1, 1978·The Journal of Experimental Medicine·V A LennonR Ulevitch
Jun 1, 1992·The Journal of Experimental Medicine·T J OglesbyJ P Atkinson
Nov 1, 1991·European Journal of Immunology·J L PlattF H Bach
Jan 1, 1989·Annual Review of Immunology·D M Lublin, J P Atkinson
Nov 1, 1989·Analytical Biochemistry·S C Gill, P H von Hippel
Dec 1, 1988·Transplantation·S MiyagawaH Kitamura
May 1, 1985·The Journal of Experimental Medicine·S Rodriguez de CordobaJ P Atkinson
Jan 1, 1985·Advances in Immunology·G D Ross, M E Medof
Feb 1, 1988·Scandinavian Journal of Immunology·T E Mollnes, P J Lachmann
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J L ColeJ P Atkinson
May 1, 1983·Human Immunology·R L Sparrow, I F McKenzie
Jan 1, 1983·Annual Review of Immunology·D T Fearon, W W Wong
May 1, 1981·The Journal of Experimental Medicine·K Iida, V Nussenzweig
Jan 1, 1981·Immunological Reviews·W H FridmanR H Gisler
Dec 1, 1982·The Journal of Clinical Investigation·J A GelfandJ F Burke
Dec 1, 1982·The Journal of Experimental Medicine·M E MedofV Nussenzweig
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·J M BergelsonR W Finberg
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·N OkadaM Caparon
Nov 1, 1993·The Journal of Experimental Medicine·F L IerinoP M Hogarth

❮ Previous
Next ❯

Citations

Jul 25, 2000·Immunopharmacology·A Sahu, J D Lambris
Dec 14, 1999·Current Opinion in Nephrology and Hypertension·J E MarshS H Sacks
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S K Shernan, C D Collard
Apr 2, 2002·Journal of Cardiac Surgery·M S SandrinI F McKenzie
Feb 17, 1997·The Journal of Experimental Medicine·J YuS Tomlinson
Jun 19, 2003·The Journal of Clinical Investigation·Hongbin SongStephen Tomlinson
Dec 7, 2007·Bioorganicheskaia khimiia·L V KozlovA P Kaplun
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A SahuJ D Lambris
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleni GiannakisDavid L Gordon
Sep 4, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Hidetaka HaraDavid K C Cooper
May 16, 2001·The Journal of Biological Chemistry·H ZhangS Tomlinson
Aug 10, 1999·Journal of Virology·D R ShafrenA Suhrbier
Mar 11, 2021·Pharmacological Reviews·Peter GarredTom E Mollnes
Jul 17, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Christine WeeksGeorge C Tsokos
Aug 31, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A M SoulikaJ D Lambris
Dec 9, 1998·Kidney International·M Nangaku
Jul 14, 2005·Molecular Immunology·Tom E Mollnes, Michael Kirschfink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.